Get started
Author

Fengna Yan

TRPV1 agonism inhibits endothelial cell inflammation via activation of eNOS/NO pathway
2017 · Youping Wang, Lin Cui, et al. · Atherosclerosis · 106
TIGIT + TIM-3 + NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
2021 · Lihua Yu, Xiaoli Liu, et al. · OncoImmunology · 94
Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
2023 · Fengna Yan, Qun Zhang, et al. · Frontiers in Cellular and Infection Microbiology · 74
PDF
A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy
2021 · Dongdong Zhou, Xiaoli Liu, et al. · BMC Cancer · 49
PDF
Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway
2019 · Chundong Song, Youping Wang, et al. · BMC Complementary and Alternative Medicine · 37
PDF
Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells
2021 · Fengna Yan, Xinhui Wang, et al. · Phytomedicine · 24
PDF
Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis
2020 · Fengna Yan, Miaomiao Feng, et al. · Cancer Cell International · 21
PDF
Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
2021 · Xinhui Wang, Xiaoli Liu, et al. · Journal of Hepatocellular Carcinoma · 16
PDF
Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
2022 · Yuqing Xie, Fengna Yan, et al. · Cancer Medicine · 14
Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation
2024 · Yu-Qing Xie, Feng-Na Yan, et al. · Journal of Ethnopharmacology · 11
Prognostic and therapeutic potential of imbalance between PD ‐1+ CD8 and ICOS +Treg cells in advanced HBV ‐ HCC
2024 · Fengna Yan, Bingbing Zhu, et al. · Cancer Science · 11
FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription
2025 · Yuqing Xie, Fengna Yan, et al. · Drug Design Development and Therapy · 3
Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study
2024 · Huiwen Yan, Xinhui Wang, et al. · Frontiers in Pharmacology · 3
PDF
Prevotella ‐Derived Butyrate Inhibits CD8 + T‐Cell Glycolysis via AKT / mTOR Signalling to Alleviate MASH
2026 · Feixiang Xiong, Fengna Yan, et al. · Liver International · 1
Alterations in NK Cell Function and Glucose Metabolism Characteristics in Patients With Progressive Hepatocellular Carcinoma
2026 · Lihua Yu, Yuyong Jiang, et al. · Immunology · 1
PDF
Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
2023 · Peng Wang, Xinhui Wang, et al. · BMC Cancer · 1
PDF
QHHP Ameliorates MASH Through Modulation of a Cyp4a32–PPARγ–CD36‐Associated Lipotoxic Axis
2026 · Feixiang Xiong, Fengna Yan, et al. · The FASEB Journal
Natural product FZJDXJ enhances CD8+ T-cell glycolysis to relieve exhaustion and augment antitumor immunity in HBV+ hepatocellular carcinoma
2026 · Fengna Yan, Yuqing Xie, et al. · Frontiers in Nutrition
Guideline for Traditional Chinese Medicine Diagnosis and Treatment of Primary Liver Cancer
2026 · Xiuhui Li, Xianbo Wang, et al. · Gastroenterology and Hepatology Research
PDF
THU-413 Multi-omics integration identifies a precise prognostic signature of survival in advanced HCC
2026 · Fengna Yan, Feixiang Xiong, et al. · Journal of Hepatology
Cognitive Biases and Practical Barriers Among Chinese Clinicians Regarding the Guidelines for the Prevention and Treatment of Chronic Hepatitis B(version 2022): Results of a Multicenter Survey
2026 · Guangyuan Huo, Yujie Guo, et al. · Research Square
PDF
Multi-Omics Integration Identifies a Prognostic Signature Guiding Precision Survival in Advanced HCC
2025 · Fengna Yan, Feixiang Xiong, et al. · SSRN Electronic Journal
Fuzheng Jiedu Xiaoji Formula Remodelled Glycolytic Metabolism Manipulate Immune Responses in Hepatocellular Carcinoma
2024 · Wang Xianbo, Fengna Yan, et al. · SSRN Electronic Journal
Prognostic and therpeutic potential of PD-1 expression imbalance between CD8+T and regulatory T cells in advanced hepatitis B virus‐associated hepatocellular carcinoma
2023 · Fengna Yan, Bingbing Zhu, et al. · Research Square
PDF
GW27-e0242 Effect of TRPV4 on renal injury induced by angiotensin II in mice
2016 · Suxiao Liu, Fengna Yan, et al. · Journal of the American College of Cardiology
Works count: 25
Citation count: 466
H-index: 11
I10-index: 11
Year
Topic
Type